Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery. The research was ...
May 9, 2018
0
1
The anti-PD1 immunotherapy nivolumab (Opdivo) given prior to surgical resection of stage 1-3 non-small cell lung cancer (NSCLC) was safe and resulted in major pathological responses in 45 percent of the patients, according ...
Apr 16, 2018
0
2
Even with pre-operative imaging techniques, surgeons still rely on visual inspection to locate malignant tissues during surgery. New research released today at the 2017 American Association of Pharmaceutical Scientists (AAPS) ...
Nov 14, 2017
0
1
Physicians at the University of Kentucky Markey Cancer Center are the first to perform a unique procedure to treat a rare and persistent type of ovarian cancer.
Sep 19, 2017
0
128
The extent of resection in patients with glioblastoma, an aggressive and often fatal brain tumor, was associated with the likelihood of survival and disease progression, according to a new study published online by JAMA Oncology.
Jun 16, 2016
0
0
(HealthDay)—For patients who develop facial paralysis after cerebellopontine angle (CPA) tumor resection, the recovery pattern in the early postoperative period is useful for selecting patients for facial reanimation surgery, ...
Dec 2, 2015
0
0
About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating ...
Aug 31, 2015
1
6
(HealthDay)—For most pregnant patients with benign spine tumors, surgery can be postponed until after delivery, according to a study published in the Feb. 1 issue of Spine.
Feb 9, 2015
0
7
(HealthDay)—For pediatric patients with stage 4 neuroblastoma, surgery of the primary tumor site has no impact on outcomes, according to a study published online Jan. 2 in the Journal of Clinical Oncology.
Jan 15, 2013
0
0
(Medical Xpress)—The use of a new brain tumor-targeting contrast agent that differentiates between normal and cancer cells in conjunction with a high-powered microscopy system could potentially lead to a method of more ...
Jan 10, 2013
0
0
